GlassScriptPhysician profile
Dawn M Pfeiffer
NPI 1346276268
$759.18
in general payments reported to CMS, 2019-2025
12 companies · $46.70 in 2025
The $46.70 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $11.35 · 2021: $126 · 2022: $16.86 · 2023: $358 · 2024: $32.81 · 2025: $46.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $242.68 | 2019-2023 | Augment Injectable, Easyfuse, Citrefix |
| Kerecis Limited | $160.12 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Biocomposites INC | $149.41 | 2023 | Stimulan |
| Bioventus LLC | $33.45 | 2023 | Exogen Ultrasound Bone Healing System |
| Phadia US INC. | $32.81 | 2024 | Immunocap |
| Merck Sharp & Dohme LLC | $32.76 | 2025 | Enflonsia, Capvaxive |
| Genentech USA, INC. | $24.66 | 2019 | |
| Abbvie INC. | $24.34 | 2023 | |
| Wright Medical Technology, INC. | $19.17 | 2019 | |
| Boston Scientific Corporation | $14.49 | 2023 | |
| Novo Nordisk INC | $13.94 | 2025 | Wegovy |
| Misonix INC | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Pfeiffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.